By Tom Zanki ( July 10, 2018, 9:26 PM EDT) -- Venture capital-backed biotechnology firm Replimune Group Inc. launched an initial public offering estimated to raise about $101 million on Tuesday, joined by a Washington state community bank planning a $38 million IPO, adding to a packed lineup of deals scheduled to price next week....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.